Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, Hunan, China.
Hunan Zaochen Nanorobot Co., Ltd, Liuyang 410300, Hunan, China.
Analyst. 2021 Nov 22;146(23):7087-7103. doi: 10.1039/d1an01371h.
The hybridization chain reaction is a very popular isothermal nucleic acid amplification technology. A single-stranded DNA initiator triggers an alternate hybridization event between two hairpins forming a double helix polymer. Due to isothermal, enzyme-free and high amplification efficiency characteristics, the HCR is often used as a signal amplification technology for various biosensing and biomedicine fields. However, as an enzyme-free self-assembly reaction, it has some inevitable shortcomings of relatively slow kinetics, low cell internalization efficiency, weak biostability of DNA probes and uncontrollable reaction in these applications. More and more researchers use this reaction system to synthesize new materials. New materials can avoid these problems skillfully by virtue of their inherent biological characteristics, molecular recognition ability, sequence programmability and biocompatibility. Here, we summarized the traditional application of the HCR in biosensing and biomedicine in recent years, and also introduced its new application in the synthesis of new materials for biosensing and biomedicine. Finally, we summarized the development and challenges of the HCR in biosensing and biomedicine in recent years. We hope to give readers some enlightenment and help.
杂交链式反应是一种非常流行的等温核酸扩增技术。单链 DNA 引发剂触发两个发夹之间的交替杂交事件,形成双链聚合物。由于等温、无酶和高扩增效率的特点,HCR 常被用作各种生物传感和生物医学领域的信号放大技术。然而,作为一种无酶的自组装反应,它具有一些不可避免的缺点,如动力学相对较慢、细胞内化效率低、DNA 探针的生物稳定性弱以及在这些应用中无法控制反应。越来越多的研究人员利用该反应体系来合成新材料。新材料可以巧妙地利用其固有的生物特性、分子识别能力、序列可编程性和生物相容性来避免这些问题。在这里,我们总结了近年来 HCR 在生物传感和生物医学中的传统应用,同时也介绍了其在生物传感和生物医学中新材料合成方面的新应用。最后,我们总结了近年来 HCR 在生物传感和生物医学中的发展和挑战。我们希望能给读者一些启发和帮助。